{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:31Z","timestamp":1792701631836,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA76184"],"award-info":[{"award-number":["R01 CA76184"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["CHD1-KO"],"award-info":[{"award-number":["CHD1-KO"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["SCR_018361"],"award-info":[{"award-number":["SCR_018361"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["CHD1-WT"],"award-info":[{"award-number":["CHD1-WT"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PC150211"],"award-info":[{"award-number":["PC150211"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["P50 CA269011"],"award-info":[{"award-number":["P50 CA269011"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007923","name":"University of Wisconsin Carbone Cancer Center","doi-asserted-by":"publisher","award":["SCR_017757"],"award-info":[{"award-number":["SCR_017757"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007923","name":"University of Wisconsin Carbone Cancer Center","doi-asserted-by":"publisher","award":["SCR_025085"],"award-info":[{"award-number":["SCR_025085"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007923","name":"University of Wisconsin Carbone Cancer Center","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/100007923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007881","name":"Fondation pour la M\u00e9decine de Laboratoire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neo.2026.101289","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:31:23Z","timestamp":1771475483000},"page":"101289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-4253","authenticated-orcid":false,"given":"Tanaya A.","family":"Purohit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gawdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachery","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-1773","authenticated-orcid":false,"given":"Truman J.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4321-8474","authenticated-orcid":false,"given":"Rehaan","family":"Machhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Sardeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0327-997X","authenticated-orcid":false,"given":"Mohammad","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-1304","authenticated-orcid":false,"given":"Anupama","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Esbona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-4188","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-5405","authenticated-orcid":false,"given":"Marjorie L.","family":"Roskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-7823","authenticated-orcid":false,"given":"Peter W.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Denu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-7165","authenticated-orcid":false,"given":"David F.","family":"Jarrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neo.2026.101289_bib0001","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Abeshouse","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neo.2026.101289_bib0002","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/acschembio.6b01035","article-title":"Identifying dysregulated epigenetic enzyme activity in castrate-resistant prostate cancer development","volume":"12","author":"Lee","year":"2017","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.neo.2026.101289_bib0004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13238-013-2093-2","article-title":"EZH2, an epigenetic driver of prostate cancer","volume":"4","author":"Yang","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.neo.2026.101289_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216815","article-title":"Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer","volume":"588","author":"Kanaoka","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101289_bib0006","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.2147\/OTT.S259873","article-title":"The role of methyltransferase NSD2 as a potential oncogene in Human solid tumors","volume":"13","author":"Chen","year":"2020","journal-title":"Onco Targets. Ther."},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0007","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/s41467-018-07511-4","article-title":"NSD2 is a conserved driver of metastatic prostate cancer progression","volume":"9","author":"Aytes","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.neo.2026.101289_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-018-0707-9","article-title":"Molecular subtypes of prostate cancer","volume":"20","author":"Arora","year":"2018","journal-title":"Curr. Oncol. Rep."},{"issue":"14","key":"10.1016\/j.neo.2026.101289_bib0009","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1093\/nar\/gkx636","article-title":"The ATP-dependent chromatin remodeler Chd1 is recruited by transcription elongation factors and maintains H3K4me3\/H3K36me3 domains at actively transcribed and spliced genes","volume":"45","author":"Lee","year":"2017","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neo.2026.101289_bib0010","article-title":"CHD1, a multifaceted epigenetic remodeler in prostate cancer","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.neo.2026.101289_bib0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/annonc\/mdx165","article-title":"CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair","volume":"28","author":"Shenoy","year":"2017","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2026.101289_bib0012","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ccell.2019.04.012","article-title":"CHD1 Loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis","volume":"35","author":"Augello","year":"2019","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neo.2026.101289_bib0013","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846783","article-title":"Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness","volume":"19","author":"Kari","year":"2018","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.neo.2026.101289_bib0014","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pros.23313","article-title":"LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease an\u2013d serve as models for evaluating cancer therapeutics","volume":"77","author":"Nguyen","year":"2017","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.neo.2026.101289_bib0015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones","volume":"2","author":"Shechter","year":"2007","journal-title":"Nat. Protocols"},{"issue":"111","key":"10.1016\/j.neo.2026.101289_bib0016","doi-asserted-by":"crossref","DOI":"10.3791\/54112","article-title":"Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis","author":"Sidoli","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neo.2026.101289_bib0017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymeth.2019.12.001","article-title":"A practical guide for analysis of histone post-translational modifications by mass spectrometry: best practices and pitfalls","volume":"184","author":"Thomas","year":"2020","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.neo.2026.101289_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41416-021-01398-7","article-title":"Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype","volume":"125","author":"Filon","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2012.05.009","article-title":"A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays","volume":"44","author":"Huang","year":"2013","journal-title":"Hum. Pathol."},{"issue":"7642","key":"10.1016\/j.neo.2026.101289_bib0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature21357","article-title":"Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer","volume":"542","author":"Zhao","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neo.2026.101289_bib0021","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1535-7163.MCT-19-1141","article-title":"Synthetic lethal metabolic targeting of androgen-deprived prostate cancer cells with Metformin","volume":"19","author":"Yang","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.neo.2026.101289_bib0022","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molcel.2020.09.028","article-title":"H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2","volume":"80","author":"Jain","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2026.101289_bib0023","unstructured":"ENCODE, ENCODE Guidelines and Best practices for RNA-seq: revised December 2016. 2016."},{"key":"10.1016\/j.neo.2026.101289_bib0024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2105-15-182","article-title":"Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads","volume":"15","author":"Jiang","year":"2014","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2026.101289_bib0026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.neo.2026.101289_bib0028","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures","volume":"19","author":"Reiner","year":"2003","journal-title":"Bioinformatics"},{"issue":"43","key":"10.1016\/j.neo.2026.101289_bib0029","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"#cr-split#-10.1016\/j.neo.2026.101289_bib0030.1","unstructured":"Korotkevich, G., et al., Fast gene set enrichment analysis. 2021"},{"key":"#cr-split#-10.1016\/j.neo.2026.101289_bib0030.2","unstructured":"bioRxiv doi: 01 February 2021, preprint: not peer reviewedhttps. 10.1101\/060012."},{"issue":"5","key":"10.1016\/j.neo.2026.101289_bib0031","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cell.2010.01.003","article-title":"Distinct factors control histone variant H3.3 localization at specific genomic regions","volume":"140","author":"Goldberg","year":"2010","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.neo.2026.101289_bib0032","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"10.1016\/j.neo.2026.101289_bib0033","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41588-024-01826-3","article-title":"Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer","volume":"56","author":"Zhao","year":"2024","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.neo.2026.101289_bib0034","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","article-title":"Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.neo.2026.101289_bib0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","article-title":"Chromatin regulator CHD1 remodels the immunosuppressive tumor microenvironment in PTEN-deficient prostate cancer","volume":"10","author":"Zhao","year":"2020","journal-title":"Cancer Discov."},{"issue":"6596","key":"10.1016\/j.neo.2026.101289_bib47","doi-asserted-by":"crossref","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neo.2026.101289_bib0036","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1172\/JCI91144","article-title":"AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis","volume":"127","author":"Li","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.neo.2026.101289_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001374","article-title":"WHSC1\/NSD2 regulates immune infiltration in prostate cancer","volume":"9","author":"Want","year":"2021","journal-title":"J. ImmunOther Cancer"},{"issue":"14","key":"10.1016\/j.neo.2026.101289_bib0038","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1021\/jacs.3c01421","article-title":"Discovery of a potent and selective targeted NSD2 degrader for the reduction of H3K36me2","volume":"145","author":"Hanley","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0039","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1186\/s12885-017-3853-9","article-title":"Dysregulation of sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes","volume":"17","author":"Damodaran","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2026.101289_bib0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.18632\/oncotarget.28477","article-title":"Development of a multiplex assay to assess activated p300\/CBP in circulating prostate tumor cells","volume":"14","author":"Filon","year":"2023","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.neo.2026.101289_bib0041","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","article-title":"Targeting the p300\/CBP axis in lethal prostate cancer","volume":"11","author":"Welti","year":"2021","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.neo.2026.101289_bib0042","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.7150\/thno.73223","article-title":"Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0043","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molcel.2012.10.008","article-title":"Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer","volume":"49","author":"Asangani","year":"2013","journal-title":"Mol. Cell"},{"issue":"17","key":"10.1016\/j.neo.2026.101289_bib0044","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-22-0631","article-title":"CHD1 Promotes sensitivity to aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101289_bib0045","article-title":"NSD2 targeting reverses plasticity and drug resistance in prostate cancer","author":"Li","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101289_bib0046","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:03:26Z","timestamp":1772165006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"alternative-id":["S1476558626000187"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101289","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101289"}}